Gaush Meditech (HKSE:02407) Total Inventories: HK$382 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02407 Gaush Meditech Ltd HKSE:02407
67 GF Score
Price HK$5.29
GF Value HK$13.40
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Gaush Meditech Total Inventories?

Gaush Meditech HKSE:02407 +7.30% 67 Total Inventories is HK$382 Mil as of Dec. 2025. GuruFocus rates HKSE:02407 with a GF Score™ of 67/100 and a GF Value™ of HK$13.40 (Possible Value Trap). The stock has 3 warning signs investors should review.

Gaush Meditech's total inventories for the quarter that ended in Dec. 2025 was HK$382 Mil. Gaush Meditech's average total inventories from the quarter that ended in Jun. 2025 to the quarter that ended in Dec. 2025 was HK$388 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Gaush Meditech's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was HK$-1.52.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Gaush Meditech's Days Inventory for the six months ended in Dec. 2025 was 156.59.

Inventory Turnover measures how fast the company turns over its inventory within a year. Gaush Meditech's Inventory Turnover for the quarter that ended in Dec. 2025 was 1.17.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Gaush Meditech's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.48.


Gaush Meditech  (HKSE:02407) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Gaush Meditech's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is

Net-Net Working Capital Per Share (Q: Dec. 2025 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(483.491+0.75 * 180.84+0.5 * 381.623-1024.245
-0-9.902)/147.888
=-1.52

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Gaush Meditech's Days Inventory for the six months ended in Dec. 2025 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2025 )/Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=388.367/452.616*365 / 2
=156.59

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Gaush Meditech's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2025 ) / Average Total Inventories (Q: Dec. 2025 )
=452.616 / 388.367
=1.17

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Gaush Meditech's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=388.367 / 803.404
=0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Gaush Meditech Total Inventories Related Terms


Gaush Meditech Total Inventories Historical Data

* Premium members only.

The historical data trend for Gaush Meditech's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gaush Meditech Total Inventories Chart

Gaush Meditech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Inventories
Get a 7-Day Free Trial 294.01 313.93 359.34 357.05 381.62

Gaush Meditech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 359.34 394.73 357.05 395.11 381.62
HKSE:02407
67GF Score
Gaush Meditech Ltd HKSE:02407
Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gaush Meditech Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of HK$382 Mil mean?
Gaush Meditech (HKSE:02407) has a Total Inventories of HK$382 Mil as of Dec. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Gaush Meditech and its competitors.
Is Gaush Meditech's Total Inventories too high?
Gaush Meditech's current Total Inventories is HK$382 Mil. Overall, Gaush Meditech has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gaush Meditech's Total Inventories compare to ABT and SYK?
Gaush Meditech's Total Inventories of HK$382 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Medical Devices & Instruments company?
A good Total Inventories depends on the Medical Devices & Instruments industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Gaush Meditech and its competitors. Gaush Meditech's current Total Inventories is HK$382 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaush Meditech stock overvalued right now?
Based on GuruFocus' analysis, Gaush Meditech (HKSE:02407) is currently considered Possible Value Trap. The stock's GF Value™ is HK$13.40, compared to a current price of HK$5.29 — trading 60.5% below its estimated fair value. The current Total Inventories is HK$382 Mil. Gaush Meditech's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Gaush Meditech (HKSE:02407), the current Total Inventories is HK$382 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gaush Meditech (HKSE:02407) Overvalued in 2026?

Based on GuruFocus' analysis, Gaush Meditech stock appears to be undervalued. The current stock price of HK$5.29 is trading 60.5% below its estimated GF Value™ of HK$13.40. GuruFocus considers Gaush Meditech to be Possible Value Trap.

Key valuation signals for HKSE:02407:

  • Total Inventories: HK$382 Mil
  • GF Value™: HK$13.40 vs. price of HK$5.29 (60.5% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the HKSE:02407 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gaush Meditech Business Description

Other Exchanges F7Y:Germany
Address No.11 Dongzhimen South Avenue, Room 1901, Building A, Zhonghui Plaza, Dongcheng District, Beijing, CHN
Gaush Meditech Ltd is a provider of a broad spectrum of manufacture and sale ophthalmic medical devices and provision of technical services. The segments of the company include Proprietary products segment that derives maximum revenue, develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; Technical services segment provides warranty services, maintenance services and other related consumables; and Others segment.
67GF Score

Get the complete analysis for HKSE:02407

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$5.29
Price
HK$13.40
GF Value